Rank | Gene Set | Z-score |
---|---|---|
1 | tricarboxylic acid cycle (GO:0006099) | 7.20399976 |
2 | lysine metabolic process (GO:0006553) | 5.69935515 |
3 | lysine catabolic process (GO:0006554) | 5.69935515 |
4 | NADH metabolic process (GO:0006734) | 5.67067509 |
5 | carnitine shuttle (GO:0006853) | 5.40979750 |
6 | sarcomere organization (GO:0045214) | 5.29657617 |
7 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 5.25773138 |
8 | 2-oxoglutarate metabolic process (GO:0006103) | 5.23817219 |
9 | tricarboxylic acid metabolic process (GO:0072350) | 5.04565632 |
10 | fatty acid transmembrane transport (GO:1902001) | 4.99135920 |
11 | fatty acid beta-oxidation (GO:0006635) | 4.87585913 |
12 | aspartate family amino acid catabolic process (GO:0009068) | 4.86817384 |
13 | succinate metabolic process (GO:0006105) | 4.83510229 |
14 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 4.74046104 |
15 | oxaloacetate metabolic process (GO:0006107) | 4.71908563 |
16 | cardiac myofibril assembly (GO:0055003) | 4.60774843 |
17 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 4.56938740 |
18 | regulation of coenzyme metabolic process (GO:0051196) | 4.49732356 |
19 | regulation of cofactor metabolic process (GO:0051193) | 4.49732356 |
20 | actin-myosin filament sliding (GO:0033275) | 4.38860458 |
21 | muscle filament sliding (GO:0030049) | 4.38860458 |
22 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 4.35950300 |
23 | cullin deneddylation (GO:0010388) | 4.24024135 |
24 | fatty acid catabolic process (GO:0009062) | 4.21202368 |
25 | fatty acid oxidation (GO:0019395) | 4.19988493 |
26 | carnitine transmembrane transport (GO:1902603) | 4.19420156 |
27 | regulation of fatty acid oxidation (GO:0046320) | 4.17357458 |
28 | amino-acid betaine transport (GO:0015838) | 4.14344074 |
29 | carnitine transport (GO:0015879) | 4.14344074 |
30 | branched-chain amino acid catabolic process (GO:0009083) | 4.14284374 |
31 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 4.13148080 |
32 | valine metabolic process (GO:0006573) | 4.12137524 |
33 | lipid oxidation (GO:0034440) | 4.10836239 |
34 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 4.10739206 |
35 | regulation of sequestering of triglyceride (GO:0010889) | 4.10176984 |
36 | myofibril assembly (GO:0030239) | 4.09789973 |
37 | proteasome assembly (GO:0043248) | 4.08744731 |
38 | oxidative phosphorylation (GO:0006119) | 4.08125846 |
39 | cardiac muscle contraction (GO:0060048) | 4.05943896 |
40 | acetyl-CoA metabolic process (GO:0006084) | 4.04059767 |
41 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.98973851 |
42 | protein deneddylation (GO:0000338) | 3.96998781 |
43 | regulation of mitochondrial translation (GO:0070129) | 3.96521539 |
44 | branched-chain amino acid metabolic process (GO:0009081) | 3.95488199 |
45 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.94724251 |
46 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.94069783 |
47 | plasma membrane repair (GO:0001778) | 3.92015085 |
48 | short-chain fatty acid metabolic process (GO:0046459) | 3.90217146 |
49 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.89841614 |
50 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.89708333 |
51 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.81092144 |
52 | cellular ketone body metabolic process (GO:0046950) | 3.78059039 |
53 | glyoxylate metabolic process (GO:0046487) | 3.75412200 |
54 | negative regulation of ligase activity (GO:0051352) | 3.72226474 |
55 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.72226474 |
56 | L-serine metabolic process (GO:0006563) | 3.70236230 |
57 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.68610766 |
58 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.67385142 |
59 | monocarboxylic acid catabolic process (GO:0072329) | 3.66890448 |
60 | regulation of skeletal muscle contraction (GO:0014819) | 3.66889218 |
61 | regulation of sulfur metabolic process (GO:0042762) | 3.66161517 |
62 | ubiquinone biosynthetic process (GO:0006744) | 3.65103214 |
63 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.59186828 |
64 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.59186828 |
65 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.59186828 |
66 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.58536833 |
67 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.58536833 |
68 | establishment of integrated proviral latency (GO:0075713) | 3.57756919 |
69 | carnitine metabolic process (GO:0009437) | 3.56704354 |
70 | biotin metabolic process (GO:0006768) | 3.54497291 |
71 | positive regulation of fatty acid oxidation (GO:0046321) | 3.51811941 |
72 | actin-mediated cell contraction (GO:0070252) | 3.51729340 |
73 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.50682285 |
74 | * respiratory electron transport chain (GO:0022904) | 3.50327847 |
75 | ATP synthesis coupled proton transport (GO:0015986) | 3.48603463 |
76 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.48603463 |
77 | ubiquinone metabolic process (GO:0006743) | 3.47994398 |
78 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.47592232 |
79 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.46271536 |
80 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.46271536 |
81 | 4-hydroxyproline metabolic process (GO:0019471) | 3.46025327 |
82 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.45701575 |
83 | quaternary ammonium group transport (GO:0015697) | 3.45549351 |
84 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.45084114 |
85 | DNA damage response, detection of DNA damage (GO:0042769) | 3.44092567 |
86 | ventricular cardiac muscle cell action potential (GO:0086005) | 3.43896691 |
87 | protein complex biogenesis (GO:0070271) | 3.42143032 |
88 | * electron transport chain (GO:0022900) | 3.40945781 |
89 | fatty acid homeostasis (GO:0055089) | 3.39211280 |
90 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.39160389 |
91 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.39090592 |
92 | cardiac muscle cell development (GO:0055013) | 3.38936716 |
93 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.36979889 |
94 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.36938626 |
95 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.36549221 |
96 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.36247826 |
97 | L-phenylalanine metabolic process (GO:0006558) | 3.36247826 |
98 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.35845473 |
99 | chaperone-mediated protein transport (GO:0072321) | 3.35524415 |
100 | gluconeogenesis (GO:0006094) | 3.35123325 |
101 | creatine metabolic process (GO:0006600) | 3.34064010 |
102 | monosaccharide biosynthetic process (GO:0046364) | 3.31192106 |
103 | amino-acid betaine metabolic process (GO:0006577) | 3.30461257 |
104 | actomyosin structure organization (GO:0031032) | 3.30084714 |
105 | ketone body metabolic process (GO:1902224) | 3.29872984 |
106 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.29458768 |
107 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.29458768 |
108 | NADH dehydrogenase complex assembly (GO:0010257) | 3.29458768 |
109 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.24449844 |
110 | quinone biosynthetic process (GO:1901663) | 3.23662978 |
111 | striated muscle contraction (GO:0006941) | 3.23217865 |
112 | aldehyde catabolic process (GO:0046185) | 3.21042823 |
113 | regulation of actin filament-based movement (GO:1903115) | 3.20907773 |
114 | positive regulation of ligase activity (GO:0051351) | 3.20699052 |
115 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.20483599 |
116 | glycolytic process (GO:0006096) | 3.20214134 |
117 | alpha-linolenic acid metabolic process (GO:0036109) | 3.18386879 |
118 | L-methionine salvage (GO:0071267) | 3.16594642 |
119 | L-methionine biosynthetic process (GO:0071265) | 3.16594642 |
120 | amino acid salvage (GO:0043102) | 3.16594642 |
121 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.15377851 |
122 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.13862327 |
123 | L-phenylalanine catabolic process (GO:0006559) | 3.13862327 |
124 | cardiac cell development (GO:0055006) | 3.12031307 |
125 | positive regulation of mitochondrial fission (GO:0090141) | 3.06962469 |
126 | DNA ligation (GO:0006266) | 3.06576949 |
127 | Golgi transport vesicle coating (GO:0048200) | 3.06555958 |
128 | COPI coating of Golgi vesicle (GO:0048205) | 3.06555958 |
129 | * mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.06402406 |
130 | hexose biosynthetic process (GO:0019319) | 3.06320016 |
131 | respiratory chain complex IV assembly (GO:0008535) | 3.05164524 |
132 | heart trabecula formation (GO:0060347) | 3.05087112 |
133 | regulation of cellular amine metabolic process (GO:0033238) | 3.03849237 |
134 | cardiac muscle hypertrophy (GO:0003300) | 3.03382262 |
135 | cell communication involved in cardiac conduction (GO:0086065) | 3.00911917 |
136 | iron-sulfur cluster assembly (GO:0016226) | 2.99766158 |
137 | metallo-sulfur cluster assembly (GO:0031163) | 2.99766158 |
138 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.98747843 |
139 | aerobic respiration (GO:0009060) | 2.97346471 |
140 | regulation of relaxation of muscle (GO:1901077) | 2.96997472 |
141 | ATP biosynthetic process (GO:0006754) | 2.96088958 |
142 | inner mitochondrial membrane organization (GO:0007007) | 2.95119928 |
143 | protein targeting to mitochondrion (GO:0006626) | 2.95025739 |
144 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.93567922 |
145 | cell communication by electrical coupling (GO:0010644) | 2.93419424 |
146 | response to mercury ion (GO:0046689) | 2.92067994 |
147 | thioester biosynthetic process (GO:0035384) | 2.91627932 |
148 | acyl-CoA biosynthetic process (GO:0071616) | 2.91627932 |
149 | heart process (GO:0003015) | 2.90862084 |
150 | heart contraction (GO:0060047) | 2.90862084 |
151 | striated muscle hypertrophy (GO:0014897) | 2.89193121 |
152 | establishment of viral latency (GO:0019043) | 2.88285819 |
153 | regulation of ligase activity (GO:0051340) | 2.87034212 |
154 | tRNA aminoacylation for protein translation (GO:0006418) | 2.86585210 |
155 | carboxylic acid catabolic process (GO:0046395) | 2.86163524 |
156 | organic acid catabolic process (GO:0016054) | 2.86163524 |
157 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.82485578 |
158 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.82485578 |
159 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.79358183 |
160 | purine nucleoside monophosphate biosynthetic process (GO:0009127) | 2.77380600 |
161 | purine ribonucleoside monophosphate biosynthetic process (GO:0009168) | 2.77380600 |
162 | amino acid activation (GO:0043038) | 2.77353725 |
163 | tRNA aminoacylation (GO:0043039) | 2.77353725 |
164 | cellular respiration (GO:0045333) | 2.76967751 |
165 | cytochrome complex assembly (GO:0017004) | 2.75607105 |
166 | protein localization to mitochondrion (GO:0070585) | 2.75204073 |
167 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.74344549 |
168 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.74344549 |
169 | establishment of protein localization to mitochondrion (GO:0072655) | 2.70902374 |
170 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 2.70083413 |
171 | hydrogen ion transmembrane transport (GO:1902600) | 2.68491082 |
172 | mitochondrial transport (GO:0006839) | 2.66609798 |
Rank | Gene Set | Z-score |
---|---|---|
1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 8.34009030 |
2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.70906202 |
3 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 5.20764443 |
4 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 4.69982567 |
5 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 4.65752161 |
6 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 4.57876525 |
7 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.48617590 |
8 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.24501808 |
9 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 3.90445463 |
10 | * GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.88885775 |
11 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.88263431 |
12 | * EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.55524921 |
13 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.51853611 |
14 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.48674786 |
15 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 3.27557932 |
16 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.22572893 |
17 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.12978117 |
18 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.95147699 |
19 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.87751412 |
20 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.80801206 |
21 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.78363197 |
22 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.72224454 |
23 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.66314896 |
24 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.65088462 |
25 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.56899835 |
26 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.56740148 |
27 | * ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 2.31456413 |
28 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.28897274 |
29 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.28374508 |
30 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.26380759 |
31 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.26259969 |
32 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.26259969 |
33 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 2.18785622 |
34 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.17069280 |
35 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.16513889 |
36 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.15752958 |
37 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.11620916 |
38 | GABP_19822575_ChIP-Seq_HepG2_Human | 2.10366862 |
39 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.03170638 |
40 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.02775829 |
41 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.91310045 |
42 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.90925098 |
43 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.90476055 |
44 | * YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.89497180 |
45 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.88201270 |
46 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.86809806 |
47 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.84944324 |
48 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.84550570 |
49 | * MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.76897335 |
50 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.71182983 |
51 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.68438598 |
52 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.68289994 |
53 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.66898911 |
54 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.65392248 |
55 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.64177010 |
56 | GATA1_22025678_ChIP-Seq_K562_Human | 1.62508788 |
57 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.62258163 |
58 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.57938862 |
59 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.55967373 |
60 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.55763170 |
61 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.53828795 |
62 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.52151573 |
63 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.51054625 |
64 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.50983067 |
65 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.50925206 |
66 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.47656480 |
67 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.47469335 |
68 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.40992290 |
69 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.40432025 |
70 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.40004964 |
71 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.39123263 |
72 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.36657225 |
73 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.33836217 |
74 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.33516713 |
75 | * POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.32940040 |
76 | ATF3_27146783_Chip-Seq_COLON_Human | 1.32739699 |
77 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.28839743 |
78 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.28761880 |
79 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.27888631 |
80 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.26509044 |
81 | * KDM5A_27292631_Chip-Seq_BREAST_Human | 1.26422354 |
82 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.26320750 |
83 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.26224835 |
84 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.26053937 |
85 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.24262235 |
86 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.21350524 |
87 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.21230511 |
88 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.20979361 |
89 | * CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.20943795 |
90 | P68_20966046_ChIP-Seq_HELA_Human | 1.19548711 |
91 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.18847556 |
92 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.17310339 |
93 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.17045805 |
94 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.15857263 |
95 | * CIITA_25753668_ChIP-Seq_RAJI_Human | 1.11321679 |
96 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.09799230 |
97 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.08530804 |
98 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.08337498 |
99 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.07847152 |
100 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 1.07620576 |
101 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.05987892 |
102 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.03854727 |
103 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.03334927 |
104 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.01203549 |
105 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.99293478 |
106 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.98326790 |
107 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.98271170 |
108 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.94607482 |
109 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.93658702 |
110 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.92924482 |
111 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.92710291 |
112 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.92704757 |
113 | * SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.92621051 |
114 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.92520601 |
115 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.91797576 |
116 | GATA1_19941826_ChIP-Seq_K562_Human | 0.91387206 |
117 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.91232882 |
118 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.91132715 |
119 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.90824585 |
120 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.90562215 |
121 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.90541439 |
122 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.90479097 |
123 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.90333703 |
124 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.89275318 |
125 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.89097415 |
126 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.88244971 |
127 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.88212687 |
128 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.87174887 |
129 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 0.87134798 |
130 | * CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.87049058 |
131 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.86853107 |
132 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.86416577 |
133 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 0.86162847 |
134 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.85472688 |
135 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.85451570 |
136 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.84966858 |
137 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.84550058 |
138 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.84402992 |
139 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.84259658 |
140 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.84135758 |
141 | * FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.83961162 |
142 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.83786699 |
143 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.83427443 |
144 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.83360401 |
145 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.81730298 |
146 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.80502459 |
147 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.80490512 |
148 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.80281791 |
149 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.79895639 |
150 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.79867535 |
151 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.79194707 |
152 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.79090562 |
153 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.77967539 |
154 | * NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.77316343 |
155 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.77099966 |
156 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.76670280 |
157 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.75477664 |
158 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.74360959 |
159 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.74078049 |
160 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.73589109 |
161 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.73290162 |
162 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.72992184 |
163 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.72898716 |
164 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.71852774 |
165 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.71650131 |
166 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.71307009 |
167 | * CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.71053243 |
168 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.70984644 |
169 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.70177779 |
170 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.69795954 |
171 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.69396877 |
172 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.69030053 |
173 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.68415717 |
174 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.68317951 |
175 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.68002501 |
176 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.68001877 |
177 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.67993163 |
178 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.67452992 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002837_dystrophic_cardiac_calcinosis | 5.72606984 |
2 | MP0003646_muscle_fatigue | 4.35961152 |
3 | MP0004084_abnormal_cardiac_muscle | 3.96371277 |
4 | MP0000751_myopathy | 3.77526265 |
5 | MP0004215_abnormal_myocardial_fiber | 3.31132773 |
6 | MP0004036_abnormal_muscle_relaxation | 3.28143618 |
7 | MP0000749_muscle_degeneration | 3.09738910 |
8 | MP0002139_abnormal_hepatobiliary_system | 3.06524807 |
9 | MP0005330_cardiomyopathy | 3.00273828 |
10 | MP0004130_abnormal_muscle_cell | 2.96227825 |
11 | MP0008058_abnormal_DNA_repair | 2.92440838 |
12 | MP0005360_urolithiasis | 2.82220582 |
13 | MP0001529_abnormal_vocalization | 2.75531020 |
14 | MP0006036_abnormal_mitochondrial_physio | 2.52322386 |
15 | MP0003880_abnormal_central_pattern | 2.50026824 |
16 | MP0004087_abnormal_muscle_fiber | 2.45361164 |
17 | MP0003806_abnormal_nucleotide_metabolis | 2.44302529 |
18 | MP0000372_irregular_coat_pigmentation | 2.39045651 |
19 | MP0005085_abnormal_gallbladder_physiolo | 2.37122187 |
20 | MP0005365_abnormal_bile_salt | 2.33264273 |
21 | MP0002269_muscular_atrophy | 2.25507662 |
22 | MP0002972_abnormal_cardiac_muscle | 2.23880975 |
23 | MP0004043_abnormal_pH_regulation | 2.23152383 |
24 | MP0005670_abnormal_white_adipose | 2.11190100 |
25 | MP0005620_abnormal_muscle_contractility | 2.11183287 |
26 | MP0000750_abnormal_muscle_regeneration | 2.10284533 |
27 | MP0000747_muscle_weakness | 2.08106924 |
28 | MP0008775_abnormal_heart_ventricle | 2.07850434 |
29 | MP0003195_calcinosis | 2.02772359 |
30 | MP0005666_abnormal_adipose_tissue | 2.02764380 |
31 | MP0004145_abnormal_muscle_electrophysio | 1.95438218 |
32 | MP0002102_abnormal_ear_morphology | 1.90761479 |
33 | MP0002106_abnormal_muscle_physiology | 1.85637731 |
34 | MP0005385_cardiovascular_system_phenoty | 1.85607837 |
35 | MP0001544_abnormal_cardiovascular_syste | 1.85607837 |
36 | MP0005332_abnormal_amino_acid | 1.81404111 |
37 | MP0003137_abnormal_impulse_conducting | 1.81274926 |
38 | MP0010630_abnormal_cardiac_muscle | 1.80694563 |
39 | MP0008789_abnormal_olfactory_epithelium | 1.79259203 |
40 | MP0009840_abnormal_foam_cell | 1.77554349 |
41 | MP0002822_catalepsy | 1.74398860 |
42 | MP0003221_abnormal_cardiomyocyte_apopto | 1.71687512 |
43 | MP0003011_delayed_dark_adaptation | 1.71345763 |
44 | MP0006138_congestive_heart_failure | 1.70949985 |
45 | MP0004233_abnormal_muscle_weight | 1.69473032 |
46 | MP0003693_abnormal_embryo_hatching | 1.67406196 |
47 | MP0000013_abnormal_adipose_tissue | 1.67185788 |
48 | MP0000759_abnormal_skeletal_muscle | 1.66971679 |
49 | MP0008932_abnormal_embryonic_tissue | 1.65302590 |
50 | MP0010094_abnormal_chromosome_stability | 1.64480301 |
51 | MP0006276_abnormal_autonomic_nervous | 1.61673606 |
52 | MP0010329_abnormal_lipoprotein_level | 1.59116401 |
53 | MP0002909_abnormal_adrenal_gland | 1.57368242 |
54 | MP0003705_abnormal_hypodermis_morpholog | 1.56156670 |
55 | MP0004270_analgesia | 1.53238549 |
56 | MP0004484_altered_response_of | 1.52429749 |
57 | MP0008875_abnormal_xenobiotic_pharmacok | 1.52393265 |
58 | MP0001984_abnormal_olfaction | 1.50497980 |
59 | MP0005369_muscle_phenotype | 1.49442729 |
60 | MP0003252_abnormal_bile_duct | 1.48933541 |
61 | MP0005423_abnormal_somatic_nervous | 1.47784943 |
62 | MP0005083_abnormal_biliary_tract | 1.47757854 |
63 | MP0004185_abnormal_adipocyte_glucose | 1.46574422 |
64 | MP0005375_adipose_tissue_phenotype | 1.46114197 |
65 | MP0005394_taste/olfaction_phenotype | 1.43422561 |
66 | MP0005499_abnormal_olfactory_system | 1.43422561 |
67 | MP0003718_maternal_effect | 1.42417935 |
68 | MP0002736_abnormal_nociception_after | 1.41830146 |
69 | MP0004085_abnormal_heartbeat | 1.40216482 |
70 | MP0006035_abnormal_mitochondrial_morpho | 1.37472989 |
71 | MP0002118_abnormal_lipid_homeostasis | 1.35488447 |
72 | MP0002078_abnormal_glucose_homeostasis | 1.35263053 |
73 | MP0003111_abnormal_nucleus_morphology | 1.34977367 |
74 | MP0010030_abnormal_orbit_morphology | 1.34928598 |
75 | MP0005319_abnormal_enzyme/_coenzyme | 1.30304059 |
76 | MP0009643_abnormal_urine_homeostasis | 1.30292470 |
77 | MP0008007_abnormal_cellular_replicative | 1.27680334 |
78 | MP0004957_abnormal_blastocyst_morpholog | 1.27082801 |
79 | MP0003122_maternal_imprinting | 1.25652209 |
80 | MP0002971_abnormal_brown_adipose | 1.24735027 |
81 | MP0002332_abnormal_exercise_endurance | 1.21961379 |
82 | MP0002938_white_spotting | 1.21350972 |
83 | MP0003786_premature_aging | 1.20473962 |
84 | MP0001666_abnormal_nutrient_absorption | 1.19708242 |
85 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.17147775 |
86 | MP0006072_abnormal_retinal_apoptosis | 1.16548669 |
87 | MP0005253_abnormal_eye_physiology | 1.16150957 |
88 | MP0000003_abnormal_adipose_tissue | 1.15219941 |
89 | MP0009780_abnormal_chondrocyte_physiolo | 1.13337048 |
90 | MP0005266_abnormal_metabolism | 1.10377365 |
91 | MP0003077_abnormal_cell_cycle | 1.08084619 |
92 | MP0005535_abnormal_body_temperature | 1.05926780 |
93 | MP0002638_abnormal_pupillary_reflex | 1.05467665 |
94 | MP0003191_abnormal_cellular_cholesterol | 1.04670885 |
95 | MP0000609_abnormal_liver_physiology | 1.04422685 |
96 | MP0005171_absent_coat_pigmentation | 1.04419233 |
97 | MP0002234_abnormal_pharynx_morphology | 1.04298041 |
98 | MP0009697_abnormal_copulation | 1.04181945 |
99 | MP0000358_abnormal_cell_content/ | 1.03042515 |
100 | MP0001661_extended_life_span | 1.01573076 |
101 | MP0000230_abnormal_systemic_arterial | 1.01303070 |
102 | MP0003283_abnormal_digestive_organ | 1.00131974 |
103 | MP0008961_abnormal_basal_metabolism | 0.97421476 |
104 | MP0002751_abnormal_autonomic_nervous | 0.96680520 |
105 | MP0002877_abnormal_melanocyte_morpholog | 0.95925152 |
106 | MP0001756_abnormal_urination | 0.94287035 |
107 | MP0009046_muscle_twitch | 0.94176190 |
108 | MP0008995_early_reproductive_senescence | 0.93737386 |
109 | MP0002127_abnormal_cardiovascular_syste | 0.92690182 |
110 | MP0003828_pulmonary_edema | 0.90026222 |
111 | MP0005248_abnormal_Harderian_gland | 0.89721461 |
112 | MP0005075_abnormal_melanosome_morpholog | 0.87151126 |
113 | MP0001905_abnormal_dopamine_level | 0.85740570 |
114 | MP0001765_abnormal_ion_homeostasis | 0.85565759 |
115 | MP0005165_increased_susceptibility_to | 0.84839755 |
116 | MP0005408_hypopigmentation | 0.83247352 |
117 | MP0005451_abnormal_body_composition | 0.81843654 |
118 | MP0004142_abnormal_muscle_tone | 0.80355944 |
119 | MP0000647_abnormal_sebaceous_gland | 0.79155543 |
120 | MP0000266_abnormal_heart_morphology | 0.76584532 |
121 | MP0002090_abnormal_vision | 0.75860405 |
122 | MP0005636_abnormal_mineral_homeostasis | 0.75841831 |
123 | MP0008260_abnormal_autophagy | 0.75755351 |
124 | MP0001727_abnormal_embryo_implantation | 0.75612342 |
125 | MP0002272_abnormal_nervous_system | 0.73851631 |
126 | MP0005334_abnormal_fat_pad | 0.73623303 |
127 | MP0001346_abnormal_lacrimal_gland | 0.72813843 |
128 | MP0006292_abnormal_olfactory_placode | 0.71722550 |
129 | MP0005551_abnormal_eye_electrophysiolog | 0.70925089 |
130 | MP0008438_abnormal_cutaneous_collagen | 0.69917249 |
131 | MP0010368_abnormal_lymphatic_system | 0.68775516 |
132 | MP0001944_abnormal_pancreas_morphology | 0.68361223 |
133 | MP0003186_abnormal_redox_activity | 0.68318442 |
134 | MP0002693_abnormal_pancreas_physiology | 0.66429971 |
135 | MP0005646_abnormal_pituitary_gland | 0.66317893 |
136 | MP0005448_abnormal_energy_balance | 0.65171916 |
137 | MP0000343_altered_response_to | 0.64989144 |
138 | MP0005645_abnormal_hypothalamus_physiol | 0.64164873 |
139 | MP0002970_abnormal_white_adipose | 0.64023431 |
140 | MP0005058_abnormal_lysosome_morphology | 0.63924733 |
141 | MP0003329_amyloid_beta_deposits | 0.63633455 |
142 | MP0003566_abnormal_cell_adhesion | 0.63589851 |
143 | MP0001764_abnormal_homeostasis | 0.62604727 |
144 | MP0003953_abnormal_hormone_level | 0.62520922 |
145 | MP0002108_abnormal_muscle_morphology | 0.61925378 |
146 | MP0004019_abnormal_vitamin_homeostasis | 0.60211233 |
147 | MP0005187_abnormal_penis_morphology | 0.57420937 |
148 | MP0003567_abnormal_fetal_cardiomyocyte | 0.57340969 |
149 | MP0004147_increased_porphyrin_level | 0.56430081 |
150 | MP0003959_abnormal_lean_body | 0.55164445 |
151 | MP0009642_abnormal_blood_homeostasis | 0.54891657 |
152 | MP0002138_abnormal_hepatobiliary_system | 0.54285331 |
153 | MP0000598_abnormal_liver_morphology | 0.53013117 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Myoglobinuria (HP:0002913) | 5.44919782 |
2 | Sudden death (HP:0001699) | 4.91345952 |
3 | Hypoglycemic coma (HP:0001325) | 4.90788542 |
4 | Exercise-induced myalgia (HP:0003738) | 4.83164921 |
5 | Exercise-induced muscle cramps (HP:0003710) | 4.75606856 |
6 | Nemaline bodies (HP:0003798) | 4.63913779 |
7 | Ketoacidosis (HP:0001993) | 4.54325584 |
8 | Rhabdomyolysis (HP:0003201) | 4.13673485 |
9 | Ventricular tachycardia (HP:0004756) | 4.11023791 |
10 | Calf muscle hypertrophy (HP:0008981) | 3.95723817 |
11 | Ketosis (HP:0001946) | 3.93637103 |
12 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.79759661 |
13 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.69825671 |
14 | Palpitations (HP:0001962) | 3.66468447 |
15 | Muscle fiber splitting (HP:0003555) | 3.64803676 |
16 | Abnormal gallbladder physiology (HP:0012438) | 3.59042243 |
17 | Cholecystitis (HP:0001082) | 3.59042243 |
18 | Hepatic necrosis (HP:0002605) | 3.56970913 |
19 | Dicarboxylic aciduria (HP:0003215) | 3.51275691 |
20 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.51275691 |
21 | Hyperglycinuria (HP:0003108) | 3.37716373 |
22 | Right ventricular cardiomyopathy (HP:0011663) | 3.30852938 |
23 | Hyporeflexia of lower limbs (HP:0002600) | 3.30613273 |
24 | Hyperammonemia (HP:0001987) | 3.29792592 |
25 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.27213142 |
26 | Lipoatrophy (HP:0100578) | 3.25648641 |
27 | Asymmetric septal hypertrophy (HP:0001670) | 3.24609988 |
28 | Generalized aminoaciduria (HP:0002909) | 3.23014287 |
29 | Microvesicular hepatic steatosis (HP:0001414) | 3.21734111 |
30 | * Exercise intolerance (HP:0003546) | 3.18760669 |
31 | Atrial fibrillation (HP:0005110) | 3.17742415 |
32 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.17495622 |
33 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.17495622 |
34 | Abnormality of the calf musculature (HP:0001430) | 3.14406289 |
35 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.08735303 |
36 | Subaortic stenosis (HP:0001682) | 3.08735303 |
37 | Increased serum lactate (HP:0002151) | 3.08700986 |
38 | Bundle branch block (HP:0011710) | 3.08051841 |
39 | Dilated cardiomyopathy (HP:0001644) | 2.97864239 |
40 | Increased connective tissue (HP:0009025) | 2.96561389 |
41 | * Progressive macrocephaly (HP:0004481) | 2.95677433 |
42 | Abnormality of glycine metabolism (HP:0010895) | 2.95634260 |
43 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.95634260 |
44 | Type I transferrin isoform profile (HP:0003642) | 2.95313836 |
45 | Increased muscle lipid content (HP:0009058) | 2.94176885 |
46 | Primary atrial arrhythmia (HP:0001692) | 2.94147323 |
47 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.93265796 |
48 | Gout (HP:0001997) | 2.91283614 |
49 | Difficulty running (HP:0009046) | 2.90024929 |
50 | Supraventricular tachycardia (HP:0004755) | 2.86524889 |
51 | Supraventricular arrhythmia (HP:0005115) | 2.82490082 |
52 | EMG: myopathic abnormalities (HP:0003458) | 2.82122050 |
53 | Lipid accumulation in hepatocytes (HP:0006561) | 2.81271835 |
54 | Syncope (HP:0001279) | 2.79522675 |
55 | Rimmed vacuoles (HP:0003805) | 2.76486065 |
56 | Hepatocellular necrosis (HP:0001404) | 2.74926665 |
57 | Increased hepatocellular lipid droplets (HP:0006565) | 2.74310535 |
58 | Conjunctival hamartoma (HP:0100780) | 2.73905817 |
59 | Ragged-red muscle fibers (HP:0003200) | 2.70508039 |
60 | 3-Methylglutaconic aciduria (HP:0003535) | 2.65003768 |
61 | * Respiratory failure (HP:0002878) | 2.64250112 |
62 | Pheochromocytoma (HP:0002666) | 2.63509301 |
63 | Muscle stiffness (HP:0003552) | 2.62402846 |
64 | Ventricular arrhythmia (HP:0004308) | 2.60613055 |
65 | Myopathic facies (HP:0002058) | 2.60013074 |
66 | * Cerebral edema (HP:0002181) | 2.59974277 |
67 | Atrioventricular block (HP:0001678) | 2.59813080 |
68 | Hypoglycemic seizures (HP:0002173) | 2.59683149 |
69 | Abnormality of serum amino acid levels (HP:0003112) | 2.58225983 |
70 | Late onset (HP:0003584) | 2.57479997 |
71 | Heart block (HP:0012722) | 2.56715646 |
72 | CNS demyelination (HP:0007305) | 2.55228832 |
73 | Myotonia (HP:0002486) | 2.54319668 |
74 | * Abnormal mitochondria in muscle tissue (HP:0008316) | 2.49553918 |
75 | Prolonged QT interval (HP:0001657) | 2.48141021 |
76 | * Acute encephalopathy (HP:0006846) | 2.44978494 |
77 | Emotional lability (HP:0000712) | 2.43909311 |
78 | Degeneration of anterior horn cells (HP:0002398) | 2.43814834 |
79 | Abnormality of the anterior horn cell (HP:0006802) | 2.43814834 |
80 | Metabolic acidosis (HP:0001942) | 2.42099655 |
81 | Increased serum pyruvate (HP:0003542) | 2.39994991 |
82 | Abnormality of glycolysis (HP:0004366) | 2.39994991 |
83 | Abnormal atrioventricular conduction (HP:0005150) | 2.39994453 |
84 | Ventricular fibrillation (HP:0001663) | 2.39762353 |
85 | Type 1 muscle fiber predominance (HP:0003803) | 2.38683871 |
86 | * Lactic acidosis (HP:0003128) | 2.37007208 |
87 | Hyperglycinemia (HP:0002154) | 2.36773804 |
88 | Neuroendocrine neoplasm (HP:0100634) | 2.36624177 |
89 | Proximal tubulopathy (HP:0000114) | 2.34475554 |
90 | Increased intramyocellular lipid droplets (HP:0012240) | 2.34293000 |
91 | Xanthomatosis (HP:0000991) | 2.33324796 |
92 | Difficulty climbing stairs (HP:0003551) | 2.31813667 |
93 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.31539413 |
94 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.31539413 |
95 | Abnormal protein glycosylation (HP:0012346) | 2.31539413 |
96 | Abnormal glycosylation (HP:0012345) | 2.31539413 |
97 | Muscle fiber inclusion bodies (HP:0100299) | 2.30622945 |
98 | Abnormal gallbladder morphology (HP:0012437) | 2.30589097 |
99 | Hyperglycemia (HP:0003074) | 2.29977120 |
100 | Abnormality of alanine metabolism (HP:0010916) | 2.25145395 |
101 | Hyperalaninemia (HP:0003348) | 2.25145395 |
102 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.25145395 |
103 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.23197185 |
104 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.22922561 |
105 | Neoplasm of the adrenal gland (HP:0100631) | 2.22239445 |
106 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.21437040 |
107 | * Lethargy (HP:0001254) | 2.20644684 |
108 | Reduced antithrombin III activity (HP:0001976) | 2.20465498 |
109 | Hypoalphalipoproteinemia (HP:0003233) | 2.18264339 |
110 | Distal arthrogryposis (HP:0005684) | 2.16457236 |
111 | Increased purine levels (HP:0004368) | 2.15202618 |
112 | Hyperuricemia (HP:0002149) | 2.15202618 |
113 | Cerebral hypomyelination (HP:0006808) | 2.15115681 |
114 | * Acute necrotizing encephalopathy (HP:0006965) | 2.14065808 |
115 | Abnormality of methionine metabolism (HP:0010901) | 2.13926608 |
116 | Abnormality of purine metabolism (HP:0004352) | 2.13507703 |
117 | * Increased CSF lactate (HP:0002490) | 2.10528997 |
118 | Limb-girdle muscle atrophy (HP:0003797) | 2.07803053 |
119 | Multiple enchondromatosis (HP:0005701) | 2.07802767 |
120 | Esophageal neoplasm (HP:0100751) | 2.06799075 |
121 | Neoplasm of head and neck (HP:0012288) | 2.06799075 |
122 | Cholelithiasis (HP:0001081) | 2.06337986 |
123 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.04722119 |
124 | Increased variability in muscle fiber diameter (HP:0003557) | 2.04337415 |
125 | Neck muscle weakness (HP:0000467) | 2.03190757 |
126 | Hamartoma of the eye (HP:0010568) | 2.02085632 |
127 | Skin nodule (HP:0200036) | 2.00745229 |
128 | Large for gestational age (HP:0001520) | 2.00186906 |
129 | Intrahepatic cholestasis (HP:0001406) | 1.99904910 |
130 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.99728586 |
131 | * Mitochondrial inheritance (HP:0001427) | 1.98584586 |
132 | Nausea (HP:0002018) | 1.97614970 |
133 | Cortical dysplasia (HP:0002539) | 1.97424541 |
134 | * Vomiting (HP:0002013) | 1.97214211 |
135 | Abnormality of the labia minora (HP:0012880) | 1.96982218 |
136 | Cerebral palsy (HP:0100021) | 1.96796110 |
137 | Progressive muscle weakness (HP:0003323) | 1.96337549 |
138 | Renal Fanconi syndrome (HP:0001994) | 1.93308669 |
139 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.89670543 |
140 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.83642384 |
141 | CNS hypomyelination (HP:0003429) | 1.83025617 |
142 | Methylmalonic aciduria (HP:0012120) | 1.82544554 |
143 | Methylmalonic acidemia (HP:0002912) | 1.80249940 |
144 | Calcaneovalgus deformity (HP:0001848) | 1.80112023 |
145 | Poor suck (HP:0002033) | 1.78921066 |
146 | Type 2 muscle fiber atrophy (HP:0003554) | 1.78503307 |
147 | * Optic disc pallor (HP:0000543) | 1.76863468 |
148 | Oligomenorrhea (HP:0000876) | 1.73854049 |
149 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.73692188 |
150 | Shoulder girdle muscle weakness (HP:0003547) | 1.73206452 |
151 | Delayed CNS myelination (HP:0002188) | 1.71696515 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BCKDK | 4.93671119 |
2 | TRIB3 | 4.39082430 |
3 | TTN | 4.38890548 |
4 | PDK3 | 3.87943019 |
5 | PDK4 | 3.87943019 |
6 | PKN2 | 3.56869832 |
7 | VRK2 | 3.36106981 |
8 | NEK1 | 3.27523410 |
9 | BUB1 | 3.18394411 |
10 | OBSCN | 3.17497272 |
11 | LMTK2 | 3.10256314 |
12 | PHKG2 | 2.97859595 |
13 | PHKG1 | 2.97859595 |
14 | SRPK1 | 2.51289520 |
15 | PBK | 2.47570426 |
16 | TESK2 | 2.44339238 |
17 | INSRR | 2.30997060 |
18 | MYLK | 2.20418030 |
19 | TRIM28 | 2.17611695 |
20 | PDK2 | 2.07610557 |
21 | LIMK1 | 1.94544355 |
22 | FLT3 | 1.90103133 |
23 | EIF2AK1 | 1.88887544 |
24 | ERN1 | 1.88657833 |
25 | STK16 | 1.86768101 |
26 | TSSK6 | 1.81755133 |
27 | TESK1 | 1.77112093 |
28 | WNK4 | 1.75453304 |
29 | PINK1 | 1.74445004 |
30 | CSNK1G3 | 1.65805814 |
31 | SIK1 | 1.62401649 |
32 | MARK1 | 1.61878437 |
33 | DYRK2 | 1.56442372 |
34 | BCR | 1.53315930 |
35 | CCNB1 | 1.49512776 |
36 | TTK | 1.40878899 |
37 | TIE1 | 1.40600954 |
38 | PRKD3 | 1.40089054 |
39 | ZAK | 1.39748819 |
40 | MAP2K7 | 1.34912650 |
41 | PLK3 | 1.34325190 |
42 | DMPK | 1.32783021 |
43 | CSNK1G2 | 1.31077234 |
44 | CSNK1A1L | 1.29263640 |
45 | RIPK1 | 1.27847484 |
46 | CSNK1G1 | 1.27248562 |
47 | PDGFRA | 1.23446269 |
48 | PIK3CA | 1.14852682 |
49 | VRK1 | 1.13160809 |
50 | PAK3 | 1.11219338 |
51 | MAPKAPK3 | 1.10917817 |
52 | SCYL2 | 1.09193224 |
53 | PTK6 | 1.09063351 |
54 | EIF2AK3 | 1.08349972 |
55 | ERBB3 | 1.08094388 |
56 | MAP3K7 | 1.07758648 |
57 | MAP4K2 | 1.01096761 |
58 | MAP2K3 | 0.98956227 |
59 | DAPK1 | 0.98372260 |
60 | MKNK1 | 0.97016400 |
61 | MAP3K12 | 0.96247222 |
62 | PLK2 | 0.95577328 |
63 | SIK3 | 0.94676669 |
64 | ILK | 0.94091181 |
65 | EPHA4 | 0.92970320 |
66 | MAPK13 | 0.91230964 |
67 | PRKAA1 | 0.91112470 |
68 | CDK19 | 0.90282910 |
69 | PIM2 | 0.89321399 |
70 | PLK1 | 0.87345449 |
71 | FGFR4 | 0.83847329 |
72 | PRKD1 | 0.83718891 |
73 | KDR | 0.81698481 |
74 | MAP3K3 | 0.80648618 |
75 | MINK1 | 0.77456137 |
76 | PRKAA2 | 0.77230037 |
77 | PIK3CG | 0.76510617 |
78 | RPS6KA4 | 0.76004523 |
79 | KSR2 | 0.75103217 |
80 | CAMK2D | 0.73894298 |
81 | NME1 | 0.73440348 |
82 | WEE1 | 0.71568990 |
83 | NUAK1 | 0.69521568 |
84 | CDC7 | 0.68996296 |
85 | BRSK1 | 0.68733658 |
86 | MUSK | 0.68148929 |
87 | PLK4 | 0.67871938 |
88 | LRRK2 | 0.67228972 |
89 | AURKB | 0.65711738 |
90 | STK24 | 0.64521628 |
91 | CDC42BPA | 0.64282947 |
92 | MAP3K10 | 0.63448061 |
93 | PAK6 | 0.63057397 |
94 | MAPK12 | 0.61247738 |
95 | STK38L | 0.61243672 |
96 | ARAF | 0.60235411 |
97 | MAP2K4 | 0.60195132 |
98 | MST4 | 0.60142662 |
99 | CDK14 | 0.60124345 |
100 | CDK18 | 0.59892553 |
101 | MAPK11 | 0.58445141 |
102 | ATR | 0.57825435 |
103 | EEF2K | 0.57778934 |
104 | CSNK2A1 | 0.57203833 |
105 | PDPK1 | 0.56488101 |
106 | CAMK2B | 0.55927448 |
107 | DAPK3 | 0.55735991 |
108 | PASK | 0.54787301 |
109 | MAP3K1 | 0.53877341 |
110 | NEK9 | 0.53599458 |
111 | MAP3K2 | 0.52832181 |
112 | ERBB4 | 0.52547123 |
113 | WNK3 | 0.52507061 |
114 | CDK15 | 0.52432493 |
115 | MET | 0.51997110 |
116 | AURKA | 0.51880690 |
117 | RET | 0.51656510 |
118 | UHMK1 | 0.51459583 |
119 | STK38 | 0.51445720 |
120 | CDK11A | 0.51325149 |
121 | CAMK2A | 0.51256771 |
122 | MAPKAPK5 | 0.51208631 |
123 | PRKCH | 0.51180211 |
124 | PRKACG | 0.50177577 |
125 | ALK | 0.49932005 |
126 | ROCK1 | 0.49811964 |
127 | MAP2K1 | 0.48796047 |
128 | MAP3K5 | 0.48614495 |
129 | CAMK1D | 0.47228365 |
130 | CSNK2A2 | 0.47094796 |
131 | PDK1 | 0.44771918 |
132 | FER | 0.44569777 |
133 | CAMK2G | 0.43470389 |
134 | MAP3K11 | 0.42867053 |
135 | JAK2 | 0.42865951 |
136 | CSNK1A1 | 0.41691476 |
137 | AKT2 | 0.40751805 |
138 | RPS6KA5 | 0.40075319 |
139 | PAK1 | 0.39491802 |
140 | DYRK3 | 0.39049492 |
141 | PRKCG | 0.38416363 |
142 | PRKCE | 0.36131410 |
143 | MST1R | 0.36115006 |
144 | CAMK4 | 0.34748293 |
145 | NTRK1 | 0.33537877 |
146 | EPHB2 | 0.33083076 |
147 | CAMKK2 | 0.33004329 |
148 | EIF2AK2 | 0.32247982 |
149 | CSNK1E | 0.30847608 |
150 | PTK2 | 0.30161666 |
151 | PRKACA | 0.30008008 |
152 | NME2 | 0.29661636 |
153 | CAMKK1 | 0.29630844 |
154 | MTOR | 0.28243418 |
155 | DYRK1B | 0.27727756 |
156 | PRKG2 | 0.26832749 |
157 | PRKACB | 0.26557537 |
158 | MAP2K6 | 0.26550395 |
159 | EPHB1 | 0.23787494 |
160 | ICK | 0.23715126 |
161 | TGFBR2 | 0.23653673 |
162 | EPHA3 | 0.22480864 |
163 | MAP3K4 | 0.21644795 |
164 | TAOK1 | 0.19594365 |
165 | WNK1 | 0.19153015 |
166 | JAK1 | 0.19129872 |
167 | CAMK1 | 0.18905581 |
168 | FRK | 0.18512268 |
169 | ABL2 | 0.18468757 |
170 | SGK3 | 0.18367400 |
171 | PAK4 | 0.18364542 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 5.58495790 |
2 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 4.24410323 |
3 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.65348567 |
4 | Proteasome_Homo sapiens_hsa03050 | 3.61666287 |
5 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.40805005 |
6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.30220478 |
7 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.24928454 |
8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.79217579 |
9 | Carbon metabolism_Homo sapiens_hsa01200 | 2.71318420 |
10 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.62669731 |
11 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.49005691 |
12 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.42540679 |
13 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.96401783 |
14 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.95210374 |
15 | Parkinsons disease_Homo sapiens_hsa05012 | 1.79537377 |
16 | * Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.78953568 |
17 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.73648186 |
18 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.72278064 |
19 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.71361864 |
20 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.71134099 |
21 | Base excision repair_Homo sapiens_hsa03410 | 1.66159746 |
22 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.65862110 |
23 | Mismatch repair_Homo sapiens_hsa03430 | 1.53894612 |
24 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.53446319 |
25 | Protein export_Homo sapiens_hsa03060 | 1.51426166 |
26 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.46947794 |
27 | DNA replication_Homo sapiens_hsa03030 | 1.45561700 |
28 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.44191461 |
29 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.43390223 |
30 | Peroxisome_Homo sapiens_hsa04146 | 1.43379030 |
31 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.42622244 |
32 | RNA polymerase_Homo sapiens_hsa03020 | 1.41786463 |
33 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.39831520 |
34 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.38515706 |
35 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.35298745 |
36 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.33621565 |
37 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.33591096 |
38 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.31865594 |
39 | * Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.30311424 |
40 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.28089449 |
41 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.27189171 |
42 | Alzheimers disease_Homo sapiens_hsa05010 | 1.25802173 |
43 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.18643375 |
44 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.14822493 |
45 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.11434929 |
46 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.08625510 |
47 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.06851797 |
48 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.06146619 |
49 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.05444504 |
50 | Ribosome_Homo sapiens_hsa03010 | 1.02570966 |
51 | Spliceosome_Homo sapiens_hsa03040 | 1.01604877 |
52 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.01405129 |
53 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.00613549 |
54 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.99249335 |
55 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.98492738 |
56 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.97229905 |
57 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.97110608 |
58 | Galactose metabolism_Homo sapiens_hsa00052 | 0.96262076 |
59 | Insulin resistance_Homo sapiens_hsa04931 | 0.96019685 |
60 | Huntingtons disease_Homo sapiens_hsa05016 | 0.94493404 |
61 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.91472172 |
62 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.86675908 |
63 | Bile secretion_Homo sapiens_hsa04976 | 0.85938686 |
64 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.85053137 |
65 | RNA transport_Homo sapiens_hsa03013 | 0.84558107 |
66 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.84042244 |
67 | Purine metabolism_Homo sapiens_hsa00230 | 0.82132049 |
68 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.79471276 |
69 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.78671342 |
70 | Homologous recombination_Homo sapiens_hsa03440 | 0.76827501 |
71 | Lysine degradation_Homo sapiens_hsa00310 | 0.76804002 |
72 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.76524024 |
73 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.73815923 |
74 | RNA degradation_Homo sapiens_hsa03018 | 0.72985090 |
75 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.71880770 |
76 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.70143110 |
77 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.69791075 |
78 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.69773767 |
79 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.69452522 |
80 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.69023907 |
81 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.64675845 |
82 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.64433471 |
83 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.59151999 |
84 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.56599102 |
85 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.48015284 |
86 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.47097095 |
87 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.47057485 |
88 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.45448010 |
89 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.44794438 |
90 | Sulfur relay system_Homo sapiens_hsa04122 | 0.44724631 |
91 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.44346040 |
92 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.44009054 |
93 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.43410718 |
94 | Insulin secretion_Homo sapiens_hsa04911 | 0.43198658 |
95 | ABC transporters_Homo sapiens_hsa02010 | 0.42742222 |
96 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.42283890 |
97 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.42273865 |
98 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.41740933 |
99 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.41551330 |
100 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.40556225 |
101 | Histidine metabolism_Homo sapiens_hsa00340 | 0.38890333 |
102 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.38828096 |
103 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.34276527 |
104 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.32765763 |
105 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.32663218 |
106 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.31937625 |
107 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.30897505 |
108 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.30852631 |
109 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.30608896 |
110 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.29689146 |
111 | Basal transcription factors_Homo sapiens_hsa03022 | 0.28906569 |
112 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.28214502 |
113 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.25161415 |
114 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.24947731 |
115 | Cell cycle_Homo sapiens_hsa04110 | 0.24514227 |
116 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.24273802 |
117 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.22462393 |
118 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.22456425 |
119 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.19428883 |
120 | Phototransduction_Homo sapiens_hsa04744 | 0.16488738 |
121 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.14769103 |
122 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.13871713 |
123 | Viral myocarditis_Homo sapiens_hsa05416 | 0.12665803 |
124 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.07996794 |
125 | Retinol metabolism_Homo sapiens_hsa00830 | 0.07755428 |
126 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.06995686 |
127 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.06195199 |
128 | Circadian rhythm_Homo sapiens_hsa04710 | 0.05469591 |
129 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.05221608 |
130 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.04406575 |
131 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.04171042 |
132 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.03923243 |